Vivid Seats to Participate in Canaccord Genuity’s 41st Annual Growth Conference
August 05, 2021 16:01 ET
|
Vivid Seats LLC
CHICAGO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (“Vivid Seats” or “the Company”), a leading marketplace that utilizes its powerful technology platform to connect millions of fans with...
Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
August 05, 2021 16:01 ET
|
Keros Therapeutics, Inc.
LEXINGTON, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery,...
Codiak BioSciences Reports Second Quarter 2021 Financial Results and Operational Progress
August 05, 2021 16:01 ET
|
Codiak BioSciences, Inc.
– Initial safety and PK/PD data from Phase 1/2 study of exoSTING™ now expected in the fourth quarter of 2021 – – Initial safety and efficacy data from Phase 1 trial of exoIL-12™ in CTCL...
CymaBay Therapeutics to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021
August 05, 2021 16:01 ET
|
CymaBay Therapeutics, Inc.
NEWARK, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic...
Y-mAbs Announces Second Quarter Financial Results and Recent Corporate Developments
August 05, 2021 16:01 ET
|
Y-mAbs Therapeutics, Inc
NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and...
Spero Therapeutics Announces Second Quarter 2021 Operating Results and Provides Business Update
August 05, 2021 16:01 ET
|
Spero Therapeutics, Inc.
Tebipenem HBr on track for NDA submission in the fourth quarter of 2021 Announced $40 million equity investment from Pfizer Inc. and licensing agreement for SPR206 Initiated Phase 1 bronchoalveolar...
iCAD Reports Financial Results for the Quarter Ended June 30, 2021
August 05, 2021 16:01 ET
|
iCAD, Inc.
NASHUA, N.H., Aug. 05, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported its...
WillScot Mobile Mini Holdings Announces Second Quarter Results and Updates 2021 Outlook
August 05, 2021 16:01 ET
|
WillScot Mobile Mini Holdings Corp.
PHOENIX, Aug. 05, 2021 (GLOBE NEWSWIRE) -- WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini Holdings” or the “Company”) (Nasdaq: WSC), the North American leader in innovative flexible work...
Opiant Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update
August 05, 2021 16:01 ET
|
Opiant Pharmaceuticals, Inc.
SANTA MONICA, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug...
Assertio Reports Second Quarter 2021 Financial Results
August 05, 2021 16:01 ET
|
Assertio Holdings, Inc.
Reported Net Product Sales of $24.8 Million Raises Full Year Net Product Sales Guidance Range Narrows Previous Non-GAAP Adjusted EBITDA Guidance Range...